134 results
Page 5 of 7
424B5
5vlb 5a1t
17 Mar 11
Prospectus supplement for primary offering
12:00am
424B5
crkzfxv3yy686lzmhes
16 Mar 11
Prospectus supplement for primary offering
12:00am
6-K
di2q5v838r
19 Jan 11
Teva Congratulates Professor Moussa Youdim, Winner of the 2010 Emet Prize for Brain Science
12:00am
6-K
1u3c v5revz7l6be
9 Dec 10
Teva Announces Successful Results of Phase III Study with Oral Laquinimod for Multiple Sclerosis
12:00am
6-K
x7l t3qwm04g4t0edy
5 Nov 10
Teva Presents Respiratory Growth Strategy
12:00am
424B5
4gpqa14
16 Jun 10
Prospectus supplement for primary offering
12:00am
6-K
axpjm3m odcykkn50tsk
18 May 10
Current report (foreign)
12:00am
6-K
mik52h7
13 Apr 10
Teva Announces Copaxone? Reaches One Million Patient Years of Experience In the Treatment of Multiple Sclerosis
12:00am
6-K
0i3o 3lu12o
9 Mar 10
Teva Announces the Appointment of DR. Philip Frost As Chairman of Its Board of Directors
12:00am
6-K
cqlrspvjzeqw
25 Feb 10
Copaxone? 15-YEAR Study In Multiple Sclerosis Patients Demonstrates Robust Long-term Efficacy and Safety
12:00am
6-K
c8smzgn rmyv2x
8 Sep 09
New Teva Data Highlights Advances In MS Treatment Research
12:00am
6-K
mthrqte
18 May 09
Current report (foreign)
12:00am
F-4/A
40pqwm0e5s tvn3eom3
14 Oct 08
Registration of securities (foreign) (amended)
12:00am
F-4
8asi4 l4fmmor8
16 Sep 08
Registration of securities (foreign)
12:00am
425
EX-99.1
ygxwdrvid7j
23 Jul 08
Business combination disclosure
12:00am
6-K
EX-99.1
n24x92vmy6onp0nnq8q1
23 Jul 08
Current report (foreign)
12:00am
425
legkzm3iyvr juv3le9l
18 Jul 08
Business combination disclosure
12:00am